Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

PreveCeutical Medical (PRVCF) Stock Price & Analysis

PRVCF Stock Chart & Stats

$0.01$0.01(69.51%)
At close: 1:59 PM EDT
$0.01$0.0125$0.015$0.01753 Aug18 Aug31 Aug14 Sep28 Sep9 Oct26 Oct
Day’s Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.03
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
38.47K
Market Cap
$9.13M
Enterprise Value
$13.85M
Total Cash (Recent Filing)
$35.66K
Total Debt (Recent Filing)
$4.84M
Price to Earnings (P/E)
―
Beta
-0.13
Next Earnings
Nov 19, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Therapeutic And Delivery Pipeline

A portfolio spanning therapeutic applications and drug-delivery technologies gives PreveCeutical multiple avenues for future product development and intellectual-property monetization. If programs advance, this breadth could support licensing or partnering opportunities beyond a single candidate or indication.

Asset Base Improvement

An increase in total assets versus 2024 provides a limited sign that the company has expanded its resource base. This does not offset the equity deficit or leverage, but it may provide some additional platform for continuing research and pursuing commercialization over the medium term.

Cash-burn Visibility

Cash usage broadly tracking reported losses makes the company’s funding requirement more understandable than a situation where cash burn materially exceeds accounting losses. While still negative, this alignment can improve the visibility of near-term capital needs and operating discipline.

Bears Say

No Demonstrated Commercial Revenue

Zero reported revenue across the available periods indicates that the research portfolio has not yet translated into a demonstrated commercial business. Without product sales or other recurring operating revenue, future progress remains dependent on successful development, partnering, or intellectual-property monetization.

Negative Equity And High Leverage

Negative stockholders’ equity combined with debt materially exceeding the asset base signals a weak capital structure and limited financial flexibility. This increases dependence on external financing and can constrain investment in research, while raising the risk that future funding may be dilutive or difficult to obtain.

Persistent Cash Burn

Persistent negative operating and free cash flow means the company is not funding its activities internally and must continue consuming capital. The latest deterioration in free cash flow suggests funding needs may be rising, which can delay development priorities and increase reliance on external financing.

PreveCeutical Medical News

PRVCF FAQ

What was PreveCeutical Medical’s price range in the past 12 months?
PreveCeutical Medical lowest stock price was $0.00 and its highest was $0.03 in the past 12 months.
What is PreveCeutical Medical’s market cap?
PreveCeutical Medical’s market cap is $9.13M.
When is PreveCeutical Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PreveCeutical Medical’s earnings last quarter?
PreveCeutical Medical released its earnings results on Aug 28, 2026. The company reported -$0.001 earnings per share for the quarter.
Is PreveCeutical Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PreveCeutical Medical pay dividends?
PreveCeutical Medical does not currently pay dividends.
What is PreveCeutical Medical’s EPS estimate?
PreveCeutical Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PreveCeutical Medical have?
PreveCeutical Medical has 638,186,950 shares outstanding.
What happened to PreveCeutical Medical’s price movement after its last earnings report?
PreveCeutical Medical reported an EPS of -$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PreveCeutical Medical?
Currently, no hedge funds are holding shares in PRVCF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology